© 2013 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com
Introduction
Chagas’ disease, caused by
Trypanosoma cruzi,
is among the most important endemic parasitic
diseases. Approximately 16 to 18 million peo-
ple are infected in large areas of Latin America
(Fournet and Munoz, 2002). Over 1 million of
them will die of the disease unless considerable
advances are made (Maguire, 2006). Further-
more, there is increasing evidence that it may be
an emerging problem in the developed world,
with more than 100,000 infected persons living
in the United States of America alone (Maguire,
2006).
The drugs used for the treatment of this dis-
ease are nifurtimox, a nitrofuran derivative, and
benznidazole, a nitroimidazole derivative. Both
drugs generate severe side effects, and nifurtimox
is no longer used in several countries because of
its toxicity (Castro
et al., 2006; Croft et al., 2005).
Consequently, the need for effective anti-
Trypa-
nosoma compounds with less toxicity stimulates
the search for natural products as novel drug can-
didates with a potential clinical use (Hoffmann
et
al., 1992; González et al., 1990).
The aim of the present work was to assess the
in vitro activity of some Chilean plant extracts
against the trypomastigote forms of
Trypanosoma
cruzi. Thirty-one species of plants belonging to 28
genera in 21 families were investigated. The most
active extracts were those obtained from
Podan-
thus ovatifolius, Berberis microphylla, Kageneckia
oblonga, and Drimys winteri.
Drimys winteri (Winteraceae) is a tree of eco-
nomic and social importance with medicinal
properties in Chile. This plant contains several
sesquiterpenes of the drimane type. Leaves of
Drimys winteri are used in Chilean folk medicine
as analgesic and in anti-infl ammatory medications
(Houghton and Manby, 1998; San Martin, 1983;
Cotoras
et al., 2001; Muñoz and Fajardo, 2005;
Muñoz
et al., 2001; Ruiz et al., 2010).
Experimental
General
Column chromatography (CC) was carried
out using silica gel 60G (Merck Darmstadt, Ger-
many). Thin-layer chromatography (TLC) was
performed on silica gel GF254 (Merck) with (i)
n-hexane/ethyl acetate (8:2, v/v) and (ii) n-hex-
ane/acetone (8:2) as eluents. Spots were detected
under UV light or by spraying with Liebermann-
Burchard reagent and heating to 110 °C for 2 min.
Medicinal Plants of Chile: Evaluation of their
Anti-Trypanosoma cruzi Activity
Orlando M. Muñoz
a,
*, Juan D. Maya
b
, Jorge Ferreira
b
, Philippe Christen
c
,
José San Martin
d
, Rodrigo López-Muñoz
b
, Antonio Morello
b
,
and Ulrike Kemmerling
b
a
Department of Chemistry, Faculty of Science, University of Chile, Santiago, Chile.
Fax: 56-2 2713888. E-mail: omunoz@uchile.cl
b
Institute of Biological Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
c
School of Pharmaceutical Sciences, EPGL, University of Geneva,
University of Lausanne, 30, Quai Ernest-Ansermet, CH-1211 Geneva 4, Switzerland
d
Instituto de Biología Vegetal y Biotecnología, Universidad de Talca, Talca, Chile
* Author for correspondence and reprint requests
Z. Naturforsch.
68 c, 198 – 202 (2013); received December 15, 2011/March 7, 2013
The extracts of several plants of Central Chile exhibited anti-
Trypanosoma cruzi try-
pomastigotes activity. Most active extracts were those obtained from
Podanthus ovatifolius,
Berberis microphylla, Kageneckia oblonga, and Drimys winteri. The active extract of Drimys
winteri (IC
50
51.2
µg/mL) was purifi ed and three drimane sesquiterpenes were obtained:
polygodial, drimenol, and isodrimenin. Isodrimenin and drimenol were found to be active
against the trypomastigote form of
T. cruzi with IC
50
values of 27.9 and 25.1
µ
M
, respectively.
Key words: Anti- Trypanosoma cruzi, Drimenol, Isodrimenin
O. M. Muñoz
et al. · Antichagasic Plant Extracts
199
Preparative TLC was performed on 2 mm thick
silica gel F254 plates (Merck) and on a chroma-
totron (Harrison-Research Model 7924 T; Palo
Alto, CA, USA) with 1-mm and 2-mm discs, using
silica gel 60 PF 254 (Merck). Flash chromatogra-
phy was performed on silica gel 60 H (Merck)
with an
n-hexane/ethyl acetate gradient (0, 1, 5,
10, 50, 100% ethyl acetate). Melting points are un-
corrected. Optical rotations were measured with
a Perkin Elmer 241 MC polarimeter (Waltham,
MA, USA).
1
H and
13
C NMR spectra were recorded in
CDCl
3
, at 400 and 500 MHz for
1
H NMR and
100 and 125 MHz for
13
C NMR, on a Bruker
Avance AM-400 spectrometer (Karlsruhe, Ger-
many).
The
1
H NMR spectra used for the measure-
ment of the coupling constants and the HMBC
spectra used for the determination of the con-
nectivity of substituents were recorded in CDCl
3
on a Bruker-DRX 500 MHz instrument. The
1
H
Larmor frequency was determined using a 5-mm
QPN direct detection probe. Chemical shifts (δ in
ppm) are relative to the internal standard tetra-
methylsilane (TMS). 1D (
1
H,
13
C) and 2D (COSY,
HMQC, HMBC) experiments were performed
using standard Bruker microprograms.
Plant materials
Ethnopharmacological and ethnobotanical lite-
rature was obtained from Instituto de Biología
Vegetal y Biotecnología, Universidad de Talca,
Talca, Chile, and from the Departamento de
Botanica, Facultad de Ciencias, Universidad de
Chile, Santiago, Chile. Thirty-one plant species
were included in the study and collected in Cen-
tral Chile (Coastal Range, Maule Region) during
the fl owering season in January 2009 and 2010,
and identifi ed by one of us (J. S. M.). Voucher
specimens are deposited and kept in the Instituto
de Biología Vege tal y Biotecnología, Universidad
de Talca. Plants used in this study are listed in
Table I.
Extraction
The collected plants were washed with distilled
water and dried on absorbing paper at an ambi-
ent temperature of 25 – 30 °C in open air in the
shade for 5 – 10 d. The dried plant samples were
powdered and stored at ambient temperature
in amber glass bottles until use. The powdered
plant materials (10.0 – 80.0 g) were extracted with
dichloromethane (4.0 mL/g plant) or methanol/
water (4:1, v/v; 4.0 mL/g plant) for 4 h at room
temperature. The extracts were fi ltered and evap-
orated to dryness under vacuum. The residues
Table I. Chilean plant species used in this study.
No. Species, family
1 Podanthus ovatifolius Lag., Asteraceae
2 Cryptocarya alba (Mol.) Looser, Lauraceae
3 Escallonia illinita K. Presl., Saxifragaceae
4 Blepharocalyx cruckshanksii (H. et A.) Nied.,
Myrtaceae
5 Satureja gilliesii (Graham) Briq., Lamiaceae
6 Drimys winteri J. R. Forst. et G. Forst., Winteraceae
7 Luma chequen (Mol.) A. Gray, Myrtaceae
8 Luma apiculata (DC.) Burret, Myrtaceae
9 Fuchsia magellanica Lam., Onagraceae
10 Colliguaja odorifera Mol., Euphorbiaceae
11 Ugni molinae Turcz., Myrtaceae
12 Alstroemeria revoluta Ruiz et Pav., Amaryllidaceae
13 Pitavia punctata Mol., Rutaceae
14 Podocarpus saligna D. Don, Podocarpaceae
15 Lapageria rosea Ruiz et Pav., Philesiaceae
16 Schinus latifolius (Gill. ex Lindl.) Engler, Anacar-
diaceae
17 Kageneckia oblonga Ruiz et Pav., Rosaceae
No. Species, family
18 Margyricarpus pinnatus (Lam.) Kuntze, Rosaceae
19 Pseudognaphalium vira vira (Mol.) A. Anderb.,
Asteraceae
20 Eupatorium salvia Colla, Asteraceae
21 Baccharis concava (Ruiz et Pav.) Pers., Asteraceae
22 Viviania crenata (Hook.) G. Don ex H. et A., Ru-
biaceae
23 Fabiana imbricata Ruiz et Pav., Solanaceae
24 Myoschilos oblonga Ruiz et Pav., Santalaceae
25 Berberis darwinii Hook., Berberidaceae
26 Maytenus chubutensis (Speg.) Lourt., O’Donell et
Sleum., Celastraceae
27 Myrceugenia chrysocarpa (O. Berg) Kausel, Myrta-
ceae
28 Elytropus chilensis (A. DC.) Muell. Arg., Apocyn-
aceae
29 Berberis serrato-dentata Lechler, Berberidaceae
30 Berberis microphylla G. Forst., Berberidaceae
31 Pseudopanax laetevirens (Gay) Franch., Araliaceae
200
O. M. Muñoz
et al. · Antichagasic Plant Extracts
were weighed and solubilized in dimethylsulfox-
ide (DMSO) for biological assays.
Culture of trypomastigotes
African green monkey Vero cells were infected
by co-incubation of a culture of epimastigotes in
the late stationary phase, which contains about
5% of the infective trypomastigote form (Con-
treras
et al., 1985). Subsequently, the trypomas-
tigotes harvested from this culture were used to
further reinfect cultures of Vero cells at a density
of 1 · 10
6
cells/25 cm
2
, in a proportion of parasites
to cells of 2:1. Vero cell cultures infected with
trypomastigotes were incubated at 37 °C in hu-
midifi ed air and 5% CO
2
for 5 – 7 d. After that
time, the culture medium was collected and cen-
trifuged at 3,000 x
g for 5 min, and the resulting
trypomastigote-containing pellet was resuspend-
ed at a density of 1 · 10
7
parasites/mL in RPMI
1640 culture medium (without phenol red).
Trypomastigote viability assay
Viability assays were performed using the
formazan formation method, called 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay, as previously described (Faun-
dez
et al., 2005; Mosmann, 1986). Briefl y, 1 · 10
7
trypomastigotes were incubated in RPMI 1640
culture medium at 37 °C for 24 h with and with-
out addition of the extracts at fi nal concentra-
tions of 10 – 500
µg/mL. Formazan formation was
measured at 570 nm in a multi-well reader (Lab
systems Multiskan MS, Vantaa, Finland).
Characterization of compounds isolated from
Drimys winteri
Barks of
D. winteri were dried in an air-forced
oven at 40 °C for 48 h. Four hundred fi fty g of
chopped and powdered bark material were ex-
tracted with
n-hexane (2 x 2.0 L) for 24 h in a
Soxhlet extractor. Filtration followed by evapora-
tion of the solvent under reduced pressure (0.21
atm) at 25 – 30 °C gave a yellowish oily residue
(30.0 g).
The crude
n-hexane extract was fi rst subjected
to fl ash CC (silica gel, 230 – 400 mesh, 650 g), then
fractionated by gradient elution (100%
n-hexane
to 100% ethyl acetate) to give individual frac-
tions which were further purifi ed by two silica
gel columns. Elution with
n-hexane/ethyl acetate
(98:2 – 90:10) yielded 2.84 g of a yellow mixture
consisting of two compounds. Further separation
on the chromatotron afforded 0.85 g of polygo-
dial and 0.015 g of drimenol. The ethanol fraction
(2.5 g) was subjected to CC on silica gel and sepa-
rated by gradient elution (dichloromethane/meth-
anol) to afford isodrimenin. The compounds were
identifi ed by spectral data (IR,
1
H NMR, and
13
C
NMR), which were in good agreement to those
previously published (Cicció, 1984; Jansen and
Groot,
2004; McCallion, 1982; Aasen et al., 1977;
White and Burton, 1985), and by direct compari-
son with authentic samples.
Results and Discussion
Table I shows the 31 plants used in this study
from which dichloromethane and methanol/wa-
ter extracts were prepared and tested against
trypomastigotes in concentrations of up to
500
µg/mL. Table II shows the activities of ex-
tracts of
Podanthus ovatifolius, Berberis micro-
phylla, Kageneckia oblonga, and Drimys winteri,
the four plants that produced signifi cant inhibi-
tion in the MTT test. These plant extracts ex-
hibited activities between 7 and 5% of those of
the standard compounds benznidazole or nifur-
timox, respectively. The extracts from all other
plants in Table I showed an IC
50
value higher
than 500
µg/mL. Table III shows the activities of
isodrimenin, drimenol, and polygodial, the three
Table II. Activity of Chilean plant extracts on the
Tryp-
anosoma cruzi trypomastigotes.
Plant
Extract
MTT viability test
IC
50
[
µg/mL]
Mitique (
Podanthus
ovatifolius)
Methanol/water
40.1 3.0
Michay (
Berberis
microphylla)
Methanol/water
38.4 5.0
Bollén (
Kageneckia
oblonga)
Methanol/water
35.7 4.0
Canelo
( Drimys
winteri)
Dichloro-
methane
51.2 2.0
Nifurtimox
-
4.6 0.1
Benznidazole
-
8.4 0.1
The MTT assay was carried out with the trypomastigote
form of
T. cruzi. Extracts were used at fi nal concen-
trations of 10, 15, 20, 50, 100, and 500
µg/mL. IC
50
val-
ues were calculated from drug concentration-response
curves (see Experimental). Results are shown as the
average standard deviation of three independent ex-
periments.
O. M. Muñoz
et al. · Antichagasic Plant Extracts
201
sesquiterpenes isolated from the stem bark of
Drimys winteri (Fig. 1). The results show that
polygodial, the most active antifungal (Kubo
et
al., 2001), antifeedant (Zapata et al., 2009), and
antibacterial (Kubo
et al., 2005) from D. winteri,
has a weak anti-
Trypanosoma activity with re-
spect to the other sesquiterpenes. Isodrimenin
and drimenol showed similar activities as nifur-
timox or benznidazole (Table III). Some com-
pounds of the other three active plant extracts
are being isolated and their antiparasite activity
will be tested later.
Plant metabolites active against
T. cruzi have
been recently reviewed by our laboratories (Maya
et al., 2007; Salas et al., 2011), and we concluded
that the compounds isodrimenin and drimenol
isolated from
Drimys winteri represent new basic
lead structures to obtain new selective anticha-
gasic drugs.
Acknowledgements
This research was funded by World Bank-CON-
ICYT ACT-112 and Fondecyt-Chile No. 1090078
and 11110182. The authors thank Dr. Yedy Israel
for his comments on the manuscript.
Aasen A. J., Nishida J., Enzell C. D., and Appel H. H.
(1977), The structure of (11ξ,12ξ)-11,12-di(7-drimen-
11-oxy)-11,12-epoxy-7-drimene. Acta Chem. Scand.
31B, 51 – 55.
Castro J. A., Mecca M. M., and Bartel L. C. (2006), Toxic
side effects of drugs used to treat Chagas’ disease
(American trypanosomiasis). Hum. Exp. Toxicol.
25,
471 – 479.
Cicció J. (1984), Poligodial, constituyente mayoritario
de la corteza de
Drimys granadensis L. F. (Winter-
aceae). Ing. Cienc. Quím.
8, 45 – 46.
Contreras V. T., Salles J. M., Thomas N., Morel C. M.,
and Goldenberg S. (1985),
In vitro differentiation of
Trypanosoma cruzi under chemically defi ned condi-
tions. Mol. Biochem. Parasitol.
16, 315 – 327.
Cotoras M., Garcia C., Lagos C., Folch C., and Mendoza
L. (2001), Antifungal activity on
Botrytis cinerea of
fl avonoids and diterpenoids isolated from the surface
of
Pseudognaphalium spp. Bol. Soc. Chil. Quím. 46,
433 – 440.
Croft S. L., Barrett M. P., and Urbina J. (2005), Chemo-
therapy of trypanosomiases and leishmaniasis. Trends
Parasitol.
21, 508 – 512.
Faundez M., Pino P., Letelier P., Ortiz C., López R.,
Seguel C., Ferreira J., Pavani M., Morello A., and
Maya J. D. (2005), Buthionine sulfoximine increases
the toxicity of nifurtimox and benznidazole to
Tryp-
anosoma cruzi. Antimicrob. Agents Chemother. 49,
126 – 130.
Fournet A. and Munoz V. (2002), Natural products as
trypanocidal, antileishmanial and antimalarial drugs.
Curr. Top. Med. Chem.
2, 1215 – 1237.
González A. G., Bermejo J., Diaz J., Rodriguez E. M.,
Perez A., Yanes A., Rauter P., and Pozo J. (1990), Di-
terpenes and other constituents of
Eupatorium sal-
via. Phytochemistry 29, 321 – 323.
Hoffmann A., Lastra J., Veghazi E., and Farga C. (1992),
Plantas medicinales de uso común en Chile, 2 ed.
Fundación Cludio Gay, Santiago, Chile, p. 273.
Table III. Activity of compounds isolated from
Drimys
winteri upon the Trypanosoma cruzi trypomastigote
form.
Compound
IC
50
[
µ
M
]
Isodrimenin
27.9 0.3
Drimenol
25.1 0.5
Polygodial
120.4 1.5
Nifurtimox
16.1 0.2
Benznidazole
32.2 0.3
The activity was measured on
T. cruzi trypomastigotes
using the MTT method at the concentrations of 10, 15,
20, 50, 100, and 200
µ
M
. IC
50
values were calculated from
drug concentration-response curves (see Experimental).
Results are shown as the average standard deviation
of three independent experiments.
Fig. 1. Chemical structure of compounds isolated from
Drimys winteri.
R
1
R
2
O
O
Polygodial R
1
= R
2
= CHO
Drimenol R
1
= CH
2
OH; R
2
=CH
3
Isodrimenin
202
O. M. Muñoz
et al. · Antichagasic Plant Extracts
Houghton P. and Manby J. (1998), Medicinal plants of
the Mapuche. J. Ethnopharmacol.
13, 89 – 103.
Jansen B. M. and Groot A. (2004), Occurrence, bio-
logical activity and synthesis of drimane sesquiterpe-
noids. Nat. Prod. Rep.
21, 449 – 477.
Kubo I., Fujita K., and Lee S. H. (2001), Antifungal
mechanism of polygodial. J. Agric. Food Chem.
49,
1607 – 1611.
Kubo I., Fujita K., Lee B., and Ha T. J. (2005), Anti-
bacterial activity of polygodial. Phytother. Res.
19,
1013 – 1017.
Maguire J. H. (2006), Chagas’ disease – Can we stop the
deaths? N. Engl. J. Med.
355, 760 – 761.
Maya J. D., Cassels B. K., Vasquez P., Ferreira J.,
Faúndez M., Galanti N., Ferreira A., and Morello A.
(2007), Mode of action of natural and synthetic drugs
against
Trypanosoma cruzi and their interaction with
the mammalian host. Comp. Biochem. Physiol. Part
A: Mol. Integr. Physiol.
146, 601 – 620.
McCallion R. F. (1982), Antibiotic substances from
New Zealand plants. II. Polygodial, an anti-
Candida
agent from
Pseudowintera colorata. Planta Med. 44,
134 – 138.
Mosmann T. (1983), Rapid colorimetric assay for cel-
lular growth and survival: application to prolifera-
tion and cytotoxicity assays. J. Immunol. Methods
65,
55 – 63.
Muñoz O. and Fajardo V. (eds.) (2005), Flora de Chile:
Biologí a, farmacologí
a y quí
mica. Universidad de
Playa Ancha, Valparaíso, Chile, p. 227.
Muñoz O., Montes M., and Wilkomirsky T. (2001),
Plantas medicinales de uso en Chile: Quí
mica y
Farmacologí a, 2 ed. Editorial Universitaria, Santiago,
Chile.
Ruiz A., Gutierrez I., Mardones C., Vergara C., Herlitz
E., Vega M., Dorau C., Winterhalter P., and Von Baer
D. (2010), Polyphenols and antioxidant activity of ca-
lafate (
Berberis microphylla ) fruits and other native
berries from Southern Chile. J. Agric. Food Chem.
58,
6081 – 6089.
Salas C., Faundez M., Morello A., Maya J. D., and Tapia
R. (2011), Natural and synthetic naphthoquinones
active against
Trypanosoma cruzi: an inicial step
towards new drugs for Chagas disease. Curr. Med.
Chem.
18, 144 – 161.
San Martin J. (1983), Medicinal plants in Central Chile.
Econ. Bot.
37, 216 – 227.
White J. D. and Burton P. J. (1985), Synthese of the
insect antifeedant ()-cinnamodial and the drimane
sesquiterpenoids ()-isodrimenin and ()-fragrolide.
J. Org. Chem.
50, 357 – 364.
Zapata N., Budia F., Viñuela E., and Medina P. (2009),
Antifeedant and growth inhibitory effects of extracts
and drimanes of
Drimys winteri stem bark against
Spodoptera littoralis (Lep., Noctuidae). Ind. Crops
Prod.
30, 119 – 125.
Dostları ilə paylaş: |